2-(Propylthio)pyrimidine-4,6-diol

It typically acts as a precursor to the 5-nitro derivative, which is subsequently converted into the 4,6-dichloro intermediate used to form the core triazolopyrimidine ring system. 2-(Propylthio)pyrimidine-4,6-diol is a key early-stage intermediate in the synthesis of Ticagrelor, an antiplatelet medication marketed as Brilinta.